Astragaloside A 10mg 10mg | Purity Not Available
Adooq Bioscience
Astragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier PageSearch Results
Chondroitin sulfate 5g 5000mg | Purity Not Available
Adooq Bioscience
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars.
More Information Supplier PageChondroitin sulfate 1g 1000mg | Purity Not Available
Adooq Bioscience
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars.
More Information Supplier PageMK-8245 50mg 50mg | Purity Not Available
Adooq Bioscience
MK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.
More Information Supplier PageMK-8245 5mg 5mg | Purity Not Available
Adooq Bioscience
MK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.
More Information Supplier PageMK-8245 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
MK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.
More Information Supplier PageAstragaloside A 50mg 50mg | Purity Not Available
Adooq Bioscience
Astragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier PageLY2608204 10mg 10mg | Purity Not Available
Adooq Bioscience
LY2608204 is a potent used to treat type 2 diabetes. In a clinical trial, a study was performed to evaluate the safety and tolerability of LY2608204 in patients with type 2 diabetes.
More Information Supplier PageApatinib 50mg 50mg | Purity Not Available
Adooq Bioscience
Apatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier PageApatinib 5mg 5mg | Purity Not Available
Adooq Bioscience
Apatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier Page